Skip to Main Content

Author Details

Meghan Morrison Joly
Vanderbilt University Medical Center
2012
21
14
PMIDPaper TitleJournal TitlePublished Year
37039791Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.JAMA2023
36845316Evaluating automated electronic case report form data entry from electronic health records.J Clin Transl Sci2022
35504307Oxygen-Free Days as an Outcome Measure in Clinical Trials of Therapies for COVID-19 and Other Causes of New-Onset Hypoxemia.Chest2022
32112228Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.Drug Saf2020
33033174Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study.Mol Cancer Ther2020
29343814Intrinsic apoptotic pathway activation increases response to anti-estrogens in luminal breast cancers.Cell Death Dis2018
29358172Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and Survival.Cancer Res2018
28039357Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade.Mol Cancer Res2017
29170413MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance.Nat Commun2017
28666462Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.Breast Cancer Res2017
28886748ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation.Breast Cancer Res2017
26148232Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth.Oncogene2016
27197158Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.Cancer Res2016
26935538Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth.Oncogene2016
25590338Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.Cell Cycle2015
26132202mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis.PLoS Genet2015
25953087Activating PIK3CA Mutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer.Mol Cell Proteomics2015
25250573Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution.J Clin Invest2014
23999432ErbB3 downregulation enhances luminal breast tumor response to antiestrogens.J Clin Invest2013
22178756The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium.Proc Natl Acad Sci U S A2012
22738914Targeting eNOS in pancreatic cancer.Cancer Res2012
  • 1 - 21 of 21

Recommended Authors

Victor Olivas
University of California san francisco
Career Start Year 2012
Number of shared co-authors 1
Patrick C O'Leary
University of California San Francisco
Career Start Year 2010
Number of shared co-authors 0
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Bora Lim
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Kris C Wood
Duke University
Career Start Year 2005
Number of shared co-authors 0
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 0
Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 0
Justin Cidado
Oncology R&D
Career Start Year 2003
Number of shared co-authors 1
Alejandra Bruna
CRUK Cambridge Institute, University of Cambridge
Career Start Year 2002
Number of shared co-authors 0
Joshua Chuck Harrell
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
Andrea Bertotti
Candiolo Cancer Institute - FPO IRCCS
Career Start Year 2000
Number of shared co-authors 0
Ingrid A Mayer
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 11
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Steven J Isakoff
Massachusetts General Hospital
Career Start Year 1995
Number of shared co-authors 0
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 2
Mark M Moasser
Helen Diller Family Comprehensive Cancer Center
Career Start Year 1994
Number of shared co-authors 0
Andrei Goga
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 0
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1993
Number of shared co-authors 1
Senthil K Muthuswamy
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 1
Ron Bose
Washington University School of Medicine
Career Start Year 1991
Number of shared co-authors 1
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 1
Jos Jonkers
Oncode Institute, Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
Eldad Zacksenhaus
University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Francesco Caiazza
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1987
Number of shared co-authors 0
Stanley Lipkowitz
Center for Cancer Research, National Cancer Institute
Career Start Year 1978
Number of shared co-authors 1
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 5
Dennis J Slamon
David Geffen School of Medicine at university of california los angeles
Career Start Year 1973
Number of shared co-authors 2

Collaborators

Justin M Balko
Co-authored papers 5
Jill M Pulley
Vanderbilt University School of Medicine
Co-authored papers 3
Wesley H Self
Vanderbilt University Medical Center
Co-authored papers 3
Charles M Perou
Co-authored papers 3
Gordon R Bernard
Vanderbilt University
Co-authored papers 3
Matthew S Shotwell
Vanderbilt University Medical Center
Co-authored papers 3
James F Troendle
and Blood Institute, National Institutes of Health
Co-authored papers 2
Yves Rosenberg
National Heart Lung and Blood Institute
Co-authored papers 2
Michelle S Harkins
University of New Mexico
Co-authored papers 2
Marjolein de Wit
Virginia Commonwealth University
Co-authored papers 2
Kevin W Gibbs
Wake Forest University
Co-authored papers 2
Daniel Clark Files
Wake Forest University
Co-authored papers 2
Robert R Lavieri
Vanderbilt University Medical Center
Co-authored papers 2
Ari Moskowitz
Harvard Medical School
Co-authored papers 2
Lisa H Merck
Virginia Commonwealth University Health System
Co-authored papers 2
Matthew W Semler
Vanderbilt University Medical Center
Co-authored papers 2
Thomas Stricker
Co-authored papers 2
Christopher J Lindsell
Duke University
Co-authored papers 2
Adit A Ginde
University of Colorado School of Medicine
Co-authored papers 2
Neil E Bhola
Zai Lab (US) LLC
Co-authored papers 1
Rebecca N Jerome
12328Vanderbilt University Medical Center
Co-authored papers 1
Dan M Roden
Vanderbilt University Medical Center
Co-authored papers 1
Boyd Taylor Thompson
Massachusetts General Hospital, Harvard School of Medicine,
Co-authored papers 1
Li Wang
Vanderbilt University Medical Center
Co-authored papers 1
Heidi E Hamm
Co-authored papers 1
Jakea D Johnson
Vanderbilt University Medical Center
Co-authored papers 1
Akram Khan
Oregon Health and Science University
Co-authored papers 1
Mary K Banasiewicz
Vanderbilt University Medical Center
Co-authored papers 1
Daniel C Liebler
Co-authored papers 1
Alex C Cheng
Vanderbilt University Medical Center
Co-authored papers 1
Release 1.2